Current report filing

Document And Entity Information

Document And Entity Information
Feb. 09, 2023
Cover [Abstract]  
Document Type 8-K/A
Amendment Flag true
Amendment Description On February 13, 2023, Corbus Pharmaceuticals Holdings, Inc. (the "Company") filed a Current Report on Form 8-K (the "Original Form 8-K") to report the Reverse Stock Split. The Company is filing this amendment to the Original Form 8-K to include the disclosure contained under Item 3.03 which was inadvertently omitted from the Original Form 8-K. No other modifications have been made to the Original Form 8-K.
Document Period End Date Feb. 09, 2023
Entity Central Index Key 0001595097
Entity Emerging Growth Company false
Securities Act File Number 001-37348
Entity Incorporation, State or Country Code DE
Entity Tax Identification Number 46-4348039
Entity Address, Address Line One 500 River Ridge Drive
Entity Address, City or Town Norwood
Entity Address, State or Province MA
Entity Address, Postal Zip Code 02062
City Area Code 617
Local Phone Number 963-0100
Entity Information, Former Legal or Registered Name Not Applicable
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, par value $0.0001 per share
Trading Symbol CRBP
Security Exchange Name NASDAQ